The Clinical Course and Factors for the Progression of Uninvestigated Dyspepsia to Functional Dyspepsia

ConditionDyspepsia
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAir Force Military Medical University, China

About this trial

Dyspepsia is one of the most common gastrointestinal diseases. This disease was defined as predominant epigastric pain lasting for at least 1 month, which can be accompanied with other symptoms, such as epigastric fullness, and early satiety. Despite dyspepsia symptoms lasting for ≥1 month represented clinical problem, a longer duration of 6 months or more after first-onset symptom was required for the diagnosis of functional dyspepsia based on ROME IV criteria. It was unclear about the natural procession of first-onset dyspepsia to functional dyspepsia assessed by Rome IV or Asia criteria and possible factors associated with this progression.

Eligibility criteria

Qualifiers

Patients aged ≥ 18 years old who had first-onset dyspepsia with one or more symptoms of epigastric pain, epigastric burning, postprandial fullness, early satiation and that has lasted for more than 1 month to 3 months.

Disqualifiers

Known acute or chronic injury of liver or kidney

Obvious hematological abnormality, or endocrine and metabolic diseases

Known malignancy; Obvious cardiovascular or cerebrovascular diseases (such as coronary heart disease, arrhythmia, cerebral infarction and etc.

Other conditions which may be associated with dyspeptic symptoms (such as NSAIDs associated dyspepsia)

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

220 Participants
are grouped into 1 trial group